Granted patents on genes from Arabidopsis
One of the characteristics of bulk sequence claims in plants is that they are almost always in the form of patent applications. The applicants strategy in claiming bulk sequences is often to establish an early priority date and to later obtain granted patents on individual genes or small groups of genes derived from the initial applications. Hence , to this point, we have considered only patent applicatons. Whilst these applications have the potential to influence those working in dicot biotechnology, they are not granted patents.
Transcription Factors
In this section we will look more closely at examples of patents granted on cliams to Arabidopsis Transcription Factors (TFs).
This group was chosen because it includes patents granted to Mendel Biotechnology Inc., who have made application claims for bulk sequences from Arabidopsis. Since the applications are to transcription factors from Arabidopsis, they may also cover homologous sequences from other dicots. Thus analysis of granted patents for TFs offers the opportunity to analyse an important group of genes and also the ultimate patent claims that may evolve from bulk sequence claims.
The information contained in this page was believed to be correct at the time it was collated. New patents and patent applications, altered status of patents, and case law may have resulted in changes in the landscape. CAMBIA makes no warranty that it is correct or up to date at this time and accepts no liability for any use that might be made of it. Corrections or updates to the information are welcome. Please send an email to info@bios.net.
There are no comments.